adenine has been researched along with sarpogrelate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Itoh, T; Kajikuri, J | 1 |
Doi, K; Hamasaki, Y; Katagiri, D; Maeda-Mamiya, R; Nangaku, M; Noiri, E; Ogasawara, E; Sugaya, T; Tanaka, T; Yamamoto, T | 1 |
2 other study(ies) available for adenine and sarpogrelate
Article | Year |
---|---|
Characteristics of the actions by which 5-HT affects electrical and mechanical activities in rabbit jugular vein.
Topics: Adenine; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprost; Endothelium, Vascular; Glyburide; Immunohistochemistry; Isometric Contraction; Jugular Veins; Male; Membrane Potentials; Muscle, Smooth, Vascular; Nitric Oxide; Phenols; Rabbits; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Succinates; Sulfonamides; Vasodilation | 2011 |
A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1.
Topics: Adenine; Animals; Cells, Cultured; Disease Models, Animal; Fatty Acid-Binding Proteins; Fibrosis; In Vitro Techniques; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nephritis, Interstitial; Plasminogen Activator Inhibitor 1; Regional Blood Flow; Serotonin; Serotonin Antagonists; Succinates; Transforming Growth Factor beta1; Up-Regulation | 2013 |